WNT3A and neoplasm: In another critical study, it was shown that administration of Wnt3a-neutralizing antibodies in tumor bearing mice restrains tumor growth by potently activating DCs and boosting the expansion of tumor-specific CD8+ T cells with improved effector activities (27).